CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q3 2021 13F Holders as of 30 Sep 2021

Share change
-8,000,065
SEC-reported price per share
$1.19
Number of holders
55
Value change
-$9,795,208
Number of buys
22
Number of sells
37

Security key

14757U109

Report period

Q3 2021

Institutions

55

Top holders

10

Ownership snapshot

Top reported holders of CASI - CASI PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Consonance Capital Manage...
Disclosed value leader
Consonance Capital Manage...
Comparable rows
0/15
Latest evidence
30 Jun 2021
13F Highest disclosed value: $15,999,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Consonance Capital Management LP has the largest disclosed position value at $16M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Consonance Capital Management LP's linked filing trail.
Disclosed position value Top 5
Consonance Capital Management LP $16M
FEDERATED HERMES, INC. $15.73M
IDG-Accel China Growth Fund III A... $12.36M
VANGUARD GROUP INC $6.05M
Wellington Shields Capital Manage... $3.5M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Consonance Capital Management LP
13F
Company
13F
—
denominator unverified
$15,999,000
10,321,956 shares
— 30 Jun 2021
FEDERATED HERMES, INC.
13F
Company
13F
—
denominator unverified
$15,733,000
10,150,000 shares
— 30 Jun 2021
IDG-Accel China Growth Fund III Associates L.P.
13F
Company
13F
—
denominator unverified
$12,359,000
7,973,536 shares
— 30 Jun 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$6,053,000
3,904,627 shares
— 30 Jun 2021
Wellington Shields Capital Management, LLC
13F
Company
13F
—
denominator unverified
$3,500,000
2,258,264 shares
— 30 Jun 2021
Wellington Shields & Co., LLC
13F
Company
13F
—
denominator unverified
$2,841,000
1,832,769 shares
— 30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
55
Shares
38,670,498
Rows available
55
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
65
Q3 2021 holders
55
Holder diff
-10
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .